PGIM India Healthcare Fund

The scheme seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.

Growthvine rating: 1/5 — ranked #82 of 87 in category.

Fund basics

CategoryEquity: Sectoral
NAV₹12.47 (as of 2026-11-13)
AUM₹142 Cr
Expense ratio2.10%
RiskometerVery High
Fund managerAnandha Padmanabhan Anjeneyan
Exit load0.5% for redemption within 90 days

Performance & risk

Standard deviation0.00%
Max drawdown−14.58%
Alpha0
Beta0

Over 5 years, captured 100.8% of NIFTY Pharma's upside and 103.9% of its downside.

Market cap allocation

Large cap33.8%
Mid cap33.1%
Small cap33.1%

Concentration

Top 5 holdings39.4%
Top 10 holdings57.0%
Total holdings31

Top holdings

Top sectors

Calendar-year track record

YearReturnQuartileCategory rank
2026 (partial)26.7%Q1 (Top)#6 of 76
2025−2.7%Q3#44 of 69